Immutep IMMP
NASDAQ IMMP
$3.10 -0.16 (-4.70%)
As of: Oct 22, 2026 · 10:40 AM EDT

Immutep (IMMP) EBIT Margin (2014 - 2017)

Updated

Immutep (IMMP) reported EBIT Margin of -545.26% for the year ended Jun 30, 2026, up 49.74 percentage points from -595.00% a year earlier.

Analysis

Immutep (IMMP) EBIT Margin (2014 - 2017) Analysis & Trends

Dating back to the year ended Jun 30, 2010, Immutep's EBIT Margin record includes 13 years.

  • EBIT Margin has a four-year change of +18415.48 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 ranks as the highest annual EBIT Margin since the year ended Jun 30, 2020.
  • According to Business Quant data, EBIT Margin came in at -595.00% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,175.94 Bn 1,144.53 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 638.47 Bn 556.99 Bn 17.26 Bn 28.21%
3 AbbVie 504.39 Bn 477.51 Bn 12.70 Bn 37.86%
4 Merck 377.60 Bn 331.98 Bn 12.21 Bn -3.52%
5 Novartis Ag 304.31 Bn 268.30 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.64 Bn 241.32 Bn 12.86 Bn 20.57%
7 Amgen 242.06 Bn 197.45 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn -133.21%
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn 28.37%
10 Immutep 22.57 Mn -188.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -370.98%
Mar 31, 2017 -137.35%
Jun 30, 2016 3,420,144.49%
Mar 31, 2016 -763.62%
Jun 30, 2015 -19,635.70%
Jun 30, 2014 -83,682.43%
API Access

Immutep EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY